Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.
about
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.Pharmacochemistry of the platelet purinergic receptors.Signalling and pharmacological properties of the P2Y receptor.P2Y nucleotide receptors: promise of therapeutic applicationsPyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modificationsStructure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.2-Thiouracil deprived of thiocarbonyl function preferentially base pairs with guanine rather than adenine in RNA and DNA duplexesUDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y₁₄ receptor.Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
P2860
Q27325455-14F64A3C-27AD-479A-8827-8F9B56964BCAQ33869922-214C0840-BC49-42ED-9B54-5EC4C2F15EBEQ34033769-C83E58F8-649B-45A4-AAE9-A7876AB9AAB9Q34062142-227CD40E-E3C1-4341-A81B-00E4E36C78B0Q34109265-A92D3444-B37F-4B16-95DA-6CCC4BD4F153Q34676680-A80CBB06-79F3-46D0-A592-38118213A862Q35171601-D232DE9D-9F7B-4E29-BED5-EDD0560DC799Q35745912-6EDCD42A-09F1-4429-8551-AB073B1F2218Q35897845-9CA8AA9B-261B-4CD2-AC52-7761FBEE6B71Q36167203-75CEB60C-6CFE-4371-933D-3E3925638CA0Q36821548-46CF0D7E-7680-41DE-85CC-A9A54B51775CQ36935278-12B64404-6930-4450-A087-4E6750797FE7Q37688371-82467EF6-B930-4F1D-8AF9-D9386FE304CEQ38089738-FEB14A73-98D1-47A4-9760-3BC606D6AC9C
P2860
Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human P2Y
@nl
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@ast
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@en
type
label
Human P2Y
@nl
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@ast
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@en
prefLabel
Human P2Y
@nl
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@ast
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@en
P2093
P2860
P356
P1476
Human P2Y(14) receptor agonist ...... nt with alkyl and aryl groups.
@en
P2093
Arijit Das
Lauren E Burianek
Matthew O Barrett
T Kendall Harden
P2860
P304
P356
10.1021/JM901432G
P407
P577
2010-01-01T00:00:00Z